Featured

October 20th, 2014 | Related: , Bill Ericson, Phyllis Whiteley, Sequenta

SAN FRANCISCO--(BUSINESS WIRE)-- Sequenta, Inc., a biotechnology company developing clinical diagnostics based on immune cell receptor genes, today announced an equity investment by Celgene Corporation and other strategic investors.